Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Int. j. morphol ; 39(3): 876-885, jun. 2021. ilus, tab, graf
Artigo em Inglês | LILACS | ID: biblio-1385415

RESUMO

SUMMARY: The present study was aimed to investigate the hepatoprotective effects of date palm hydroalcoholic extract (DP)in diabetic rats using biochemical and histopathological approaches. Diabetes was induced by administration of 60 mg/kg of streptozotocin intraperitoneally. In this analysis 32 adult rats were randomly divided into four groups; group 1: non-diabetic control whic received 0.1 mL normal saline, group 2:served as non-diabetic control which treated with 270 mg/kg of DP, group 3: served as untreated diabetic, and group 4: diabetic rats treated with 270 mg/kg of DP. Diabetic rats treated with the DP extracts exhibited lower hepatic oxidative stress and lower hepatic enzymes level. Extract treatment decreased the level of malondealdehyde (MDA) as a marker of lipid peroxidation. Stereological estimations revealed a significant increase in the liver volume in diabetic rats which was reduced in DP-treated rats. Immunofluorescence staining showed high synthesis of acrolein as a byproduct of lipid proxidation. While, optical density measurement revealed significant decrease in acrolein after DP administration. Histopathological examination showed severe changes in untreated diabetic liver tissue manifested by dilated portal vein, leukocytic infiltration, fatty degeneration and necrotic nuclei, whereas, DP treatment attenuated the adverse effects of diabetes on the liver represented by relatively healthy hepatocytes and sinusoids. The obtained results indicated that date pam extract was beneficial in the prevention of diabetes-induced hepatotoxicity due to its natural antioxidant constituents. Further preclinical and clinical studies are needed for considering this plant in management of prediabetes and diabetes hepatic complications.


RESUMEN: El presente estudio tuvo como objetivo investigar los efectos hepatoprotectores del extracto hidroalcohólico (DP) de la palmera datilera en ratas diabéticas utilizando enfoques bioquímicos e histopatológicos. La diabetes fue inducida mediante la administración de 60 mg / kg de estreptozotocina por vía intraperitoneal. Se dividieron al azar 32 ratas adultas en cuatro grupos; grupo 1: control no diabético que recibió 0,1 mL de solución salina normal, grupo 2: control no diabético tratado con 270 mg / kg de DP, grupo 3: fue separado como diabético no tratado, y grupo 4: ratas diabéticas tratadas con 270 mg / kg de DP mg / kg de DP. Las ratas diabéticas tratadas con los extractos de DP mostraron menor estrés oxidativo hepático y menor nivel de enzimas hepáticas. El tratamiento con extracto disminuyó el nivel de malondealdehído (MDA) como marcador de la proxidación de lípidos. Las estimaciones estereológicas revelaron un aumento significativo en el volumen del hígado en ratas diabéticas que se redujo en las ratas tratadas con DP. La tinción por inmunofluorescencia mostró una alta síntesis de acroleína como subproducto de la proxidación de lípidos. Mientras que, la medición de la densidad óptica reveló una disminución significativa de la acroleína después de la administración de DP. El examen histopatológico mostró cambios significativos en el tejido hepático diabético no tratado manifestados por vena porta dilatada, infiltración leucocítica, degeneración grasa y núcleos necróticos, mientras que el tratamiento con DP atenuó los efectos adversos de la diabetes en el hígado representados por hepatocitos y sinusoides relativamente sanos. Los resultados obtenidos indicaron que el extracto de palmera datilera fue beneficioso en la prevención de la hepatotoxicidad inducida por diabetes debido a sus constituyentes antioxidantes naturales. Se necesitan más estudios clínicos para considerar esta planta en el manejo de la prediabetes y las complicaciones hepáticas de la diabetes.


Assuntos
Animais , Masculino , Ratos , Extratos Vegetais/uso terapêutico , Complicações do Diabetes , Phoeniceae , Hepatopatias/etiologia , Hepatopatias/tratamento farmacológico , Acroleína , Imuno-Histoquímica , Extratos Vegetais/farmacologia , Substâncias Protetoras/uso terapêutico , Modelos Animais de Doenças , Fígado/efeitos dos fármacos , Antioxidantes/uso terapêutico
2.
Ciênc. rural (Online) ; 49(8): e20190349, 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1045413

RESUMO

ABSTRACT: The objective of this study was to review technological and toxicological factors related to presence of carbonyl compounds found in wines, including acetaldehyde, formaldehyde, acrolein, ethyl carbamate (EC) and furfural. Acetaldehyde and formaldehyde may be formed through the ethanol and methanol oxidation, respectively. Acrolein may arise as a thermal degradation product of glycerol, amino acids, carbohydrates and triglycerides or by metabolic activity of microorganisms. In addition, acrolein and furfural are formed during wood combustion; therefore, these aldehydes may be present in raw materials due to the environmental contamination. Furfural is also a product of the Maillard reaction formed from sugars and amino acids, while ethyl carbamate occurs through the reaction between urea and ethanol. These compounds may react with SO2 and phenolic compounds to form non-volatile adducts, which positively modulates color stability, astringency and aroma in wine. However, when ingested through wine, electrophilic carbonyl compounds may form adducts with nucleophilic targets, such as DNA, resulting in genotoxicity along the gastrointestinal tract. Furthermore, carbonyl compounds induce the increase of reactive oxygen species and can trigger apoptosis, in addition to hepatocellular adenoma and carcinoma as a consequence of chronic hepatotoxicity. Neurodegenerative diseases may be related to the exposure to carbonyl compounds. Therefore, strategies to reduce the levels of these compounds should be studied in order to get the most out of the beneficial functional properties of wine consumption.


RESUMO: O objetivo deste estudo foi revisar os fatores tecnológicos e toxicológicos relacionados à presença de compostos carbonílicos encontrados em vinhos, incluindo acetaldeído, formaldeído, acroleína, carbamato de etila (CE) e furfural. O acetaldeído e o formaldeído podem ser formados através da oxidação do etanol e do metanol, respectivamente. A acroleína pode surgir como um produto de degradação térmica de glicerol, aminoácidos, carboidratos e triglicerídeos ou pela atividade metabólica de microorganismos. Além disso, a acroleína e o furfural são formados durante a combustão da madeira. Portanto, esses aldeídos podem estar presentes nas matérias-primas devido à contaminação ambiental. O furfural é também um produto da reação de Maillard formado a partir de açúcares e aminoácidos, enquanto o carbamato de etila ocorre através da reação entre uréia e etanol. Estes compostos podem reagir com SO2 e compostos fenólicos para formar adutos não voláteis, que modulam positivamente a estabilidade da cor, adstringência e aroma no vinho. No entanto, quando ingeridos através do vinho, os compostos carbonílicos que são eletrofílicos podem formar adutos com alvos nucleofílicos, como o DNA, resultando em genotoxicidade ao longo do trato gastrintestinal. Além disso, os compostos carbonílicos também induzem o aumento de espécies reativas de oxigênio e podem desencadear a apoptose, além de adenoma e carcinoma hepatocelular como consequência da hepatotoxicidade crônica. Doenças neurodegenerativas podem estar relacionadas à exposição aos compostos carbonílicos. Com isso, estratégias para reduzir os níveis desses compostos devem ser estudadas para obter o máximo das propriedades funcionais benéficas do consumo de vinho.

3.
Invest. clín ; 50(1): 23-33, mar. 2009. tab
Artigo em Espanhol | LILACS | ID: lil-518701

RESUMO

Se estudió el papel de la sustancia P, el óxido nítrico(ON) y las prostaglandinas (PGs) en la cistitis inducida por acroleína(ACR), para lo cual se estudiaron los cambios de las actividades de la óxido nítrico sintasa inducible(iNOS) y de la mieloperoxidasa(MPO) vesicales, así como en los niveles de PGs y de metabolitos del ON. Ratas macho Sprague-Dawley recibieron ACR (5mg/Kg, i.p), más uno de los siguientes tratamientos: Grupo 1: Salina, 0,10mL/100g i.p.; Grupo 2: Win-51.708(WIN), 25mg/Kg i.p.; Grupo 3: S-metilisotiourea(MITU), 35 mg/Kg i.p.; Grupo 4: Rofecoxib(ROF), 20mg/Kg v.o.; Grupo 5: Meloxicam(MEL), 25mg/Kg i.p.; Grupo 6: combinación MITU+ MEL. La mortalidad inducida por ACR fue parcialmente prevenida por WIN (antagonista NK1) y MITU (inhibidor iNOS). En los animales que sobrevivieron a 24 horas de exposición a ACR se encontraron cambios histológicos inflamatorios en vejiga, que se acompañaron de aumentos en la actividad MPO. También se observaron aumentos de nitratos+nitritos y PGs. El WIN no previno ninguno de estos cambios. El ROF y el MEL (inhibidores COX-2) protegieron parcialmente contra la inflamación vesical, mientras que el tratamiento con MITU fue capaz de prevenir estos cambios así como también el aumento de metabolitos del ON. La combinación MITU+MEL produjo una mayor protección contra los efectos inducidos por ACR. Estos resultados indican que el ON producido vía de la iNOS y las PGs producidas por la COX-1/COX-2, desempeñan un papel en la patogénesis de la cistitis por ACR. La ACR podría estimular a la iNOS y a las COX-1/COX-2, induciendo la migración linfocitaria, aumentos de nitratos+nitritos y de PGs.


To investigate the role of substance P(sP), nitric oxide (ON) and prostaglandins (PGs) in acrolein(ACR)-induced cystitis, we studied the changes induced by ACR on bladder inducible nitric oxide synthase(iNOS) and mieloperoxidase(MPO) activities, along with PGs and NO metabolites levels. Sprague-Dawley male rats received i.p. ACR (5mg/Kg) plus one of the following treatments: Group 1: saline 0.10 mL/100g i.p.; Group 2: Win-51.708 (WIN) 25mg/Kg i.p.; Group 3: S-metilisothiourea(MITU) 35mg/Kg i.p.; Group 4: Rofecoxib(ROF) 20mg/Kg o.p.; Group 5: Meloxicam(MEL) 25mg/Kg i.p.; Group 6: combination MITU+MEL. ACR-induced mortality was partially prevented by WIN (NK1 antagonist) and MITU (iNOS inhibitor). Animals that survived after 24h of ACR exposure, had histological inflammatory changes in bladder along with increased MPO activity. There was augmentation of nitrates+nitrites and of PGs. WIN didn’t prevent any of these effects. ROF and MEL (COX-2 inhibitors) partially protected against bladder inflammation; MITU pre-treatment was able to prevent these changes and those of NO metabolites levels. The MITU+MEL combination produced the highest protection against ACR-induced damage. These results suggest that NO produced via iNOS and PGs produced by COX-1/COX-2, have an important role in the pathogenesis of cystitis induced by ACR. ACR could stimulate iNOS and COX-1/COX-2, producing lymphocyte migration and increases of NO and PGs.


Assuntos
Animais , Ratos , Acroleína , Óxido Nítrico , Oxigenases , Peroxidase , Prostaglandinas , Bexiga Urinária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA